IL-10 and IL-10 receptor defects in humans

被引:193
|
作者
Glocker, Erik-Oliver [1 ]
Kotlarz, Daniel [2 ]
Klein, Christoph [2 ]
Shah, Neil [3 ]
Grimbacher, Bodo [4 ,5 ]
机构
[1] Univ Hosp Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany
[2] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany
[3] UCL, Great Ormond St Hosp, Dept Paediat Gastroenterol, London, England
[4] UCL, Sch Med, Dept Immunol, London W1N 8AA, England
[5] Univ Hosp Freiburg, Ctr Chron Immune Deficiency, Freiburg, Germany
关键词
IL-10; receptor; mutation; STAT3; inflammatory bowel disease; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; X-LINKED SYNDROME; INTERLEUKIN-10; RECEPTOR; IMMUNE DYSREGULATION; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CROHNS-DISEASE; HOST-DEFENSE; POLYENDOCRINOPATHY;
D O I
10.1111/j.1749-6632.2011.06339.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is chronic in nature and is characterized by abdominal pain, diarrhea, bleeding, and malabsorption. It is considered a complex multigenic and multifactorial disorder that results from disturbed interactions between the immune system and commensal bacteria of the gut. Recent work has demonstrated that IBD with an early-onset within the first months of life can be monogenic: mutations in IL-10 or its receptor lead to a loss of IL-10 function and cause severe intractable enterocolitis in infants and small children. Both IL-10 and IL-10 receptor deficiency can be successfully treated by hematopoietic stem cell transplantation.
引用
收藏
页码:102 / 107
页数:6
相关论文
共 50 条
  • [41] IL-10 INHIBITS EAE
    SKIAS, DD
    REDER, AT
    NEUROLOGY, 1995, 45 (04) : A349 - A349
  • [42] Opposing effects of IL-10
    Elisabeth Kugelberg
    Nature Reviews Immunology, 2014, 14 : 357 - 357
  • [43] The dual role of IL-10
    Mocellin, S
    Panelli, MC
    Wang, E
    Nagorsen, D
    Marincola, FM
    TRENDS IN IMMUNOLOGY, 2003, 24 (01) : 36 - 43
  • [44] IL-10 and pregnancy complications
    Azizieh, F. Y.
    Raghupathy, R.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2017, 44 (02): : 252 - 258
  • [45] IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
    Ouyang, Wenjun
    O'Garra, Anne
    IMMUNITY, 2019, 50 (04) : 871 - 891
  • [46] Antisense IL-10 abrogates the inhibitory effects of IL-10 production by transfected tumor cells
    Parker, G
    Fernandes, H
    Chong, SY
    Czarneski, J
    Ra, H
    Lin, YC
    Raveche, E
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 2000, 6 (03) : 113 - 119
  • [47] Is elevated serum IL-10 in B-CLL associated with IL-10 promoter polymorphisms?
    Chu, CC
    Reese, ST
    Goodwin, LO
    Guzowski, D
    Chandrasekaran, A
    Gawel, C
    Li, WT
    Gregersen, PK
    Yan, XJ
    Sherry, B
    Centola, M
    Allen, SL
    Rai, KR
    Chiorazzi, N
    BLOOD, 2005, 106 (11) : 350A - 350A
  • [48] Requirement for IL-10 in the development of CLL: Analysis of NZB IL-10 KO strain.
    Raveche, E
    McCarthy, B
    Chong, S
    Lin, YC
    Fernandes, H
    Ming, Z
    Czarneski, J
    BLOOD, 2002, 100 (11) : 669A - 669A
  • [49] IL-10 Gene Polymorphisms and IL-10 Serum Levels in Patients with Multiple Sclerosis in Lithuania
    Masilionyte, Ugne
    Gedvilaite, Greta
    Kaikaryte, Kriste
    Vilkeviciute, Alvita
    Kriauciuniene, Loresa
    Glebauskiene, Brigita
    Balnyte, Renata
    Liutkeviciene, Rasa
    BRAIN SCIENCES, 2022, 12 (06)
  • [50] Interleukin-10 (IL-10) augments allograft arterial disease - Paradoxical effects of IL-10 in vivo
    Furukawa, Y
    Becker, G
    Stinn, JL
    Shimizu, K
    Libby, P
    Mitchell, RN
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06): : 1929 - 1939